CD274 and neoplasm: Tumor cell-intrinsic factors that contribute to immunotherapy resistance include the expression or repression of certain genes and pathways in tumor cells, such as constitutive PD-L1 expression, loss of tumor antigen expression, and alterations in the antigen-presenting and processing machinery that prevent immune cell infiltration or function within the TME.